In this issue: Transporting human organs for transplant, reprocessed single-use devices, regulating 3D...
- Study shows traditional tests underestimate severity of glaucoma
- Unique brain activity pattern may help detect schizophrenia early
- Cambridge Consultants designs new digital health platform
- Movember: the latest tech developments in prostate cancer
- Apple Watch heart trial recruits 400,000 participants
Bay Labs and Northwestern study AI for heart disease detection
Bay Labs has partnered with Northwestern Medicine to assess the artificial intelligence (AI) based EchoGPS cardiac ultrasound guidance software suite for the detection of heart disease through cardiovascular imaging.
Chembio Ebola virus test gets FDA approval for emergency use
Point-of-care diagnostics provider Chembio Diagnostics has secured emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) to use its DPP Ebola Antigen System to detect the Ebola virus.
Oxford BioDynamics forms new alliance to identify autism biomarkers
UK-based biotechnology company Oxford BioDynamics has collaborated with Italian research and biomedical institution Casa Sollievo della Sofferenza to identify biomarkers related to autism spectrum disorder (ASD).
Study shows traditional tests underestimate severity of glaucoma
A new study at Columbia University in the US has demonstrated that most common glaucoma tests fail to identify the presence of certain vision loss, in turn missing or underestimating the disease’s severity.
Unique brain activity pattern may help detect schizophrenia early
Neuroscientists at Massachusetts Institute of Technology (MIT) have found a correlation between a brain activity pattern and development of schizophrenia.
Cambridge Consultants designs new digital health platform
UK-based research and development (R&D) firm Cambridge Consultants has developed a new digital platform, called Verum, to enhance healthcare delivery.
US researchers find possible biomarkers for Zika-related birth defects
Researchers at the University of Southern California (USC) in the US have discovered potential Zika biomarkers related to severe birth defects in babies who are born to women infected with the virus.
Movember: the latest tech developments in prostate cancer
It’s the start of Movember, the month when men in the UK are famously encouraged to grow a moustache in aid of raising awareness of men’s health conditions, including prostate cancer. Here are some of the latest tech trends for the UK’s deadliest male cancer.
Emerging Trends in Wearable Technology
This white paper gives an overview of current trends in wearable technologies, and dives deeper into emerging applications in diverse markets with a special focus on B2B applications, including healthcare, industry, robotics, defense and sport.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.